tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR
US Market

Pharming Group (PHAR) Technical Analysis

Compare
132 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Pharming Group’s (PHAR) Moving Averages Convergence Divergence (MACD) indicator is 0.53, suggesting Pharming Group is a Buy.
Pharming Group’s (PHAR) 20-Day exponential moving average is 10.97, while Pharming Group’s (PHAR) share price is $11.32, making it a Buy.
Pharming Group’s (PHAR) 50-Day exponential moving average is 10.10, while Pharming Group’s (PHAR) share price is $11.32, making it a Buy.

Pharming Group (PHAR) Pivot Points

Jun 17, 2025, 06:44 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.59
10.00
10.38
10.79
11.16
11.57
11.95
Fibonacci
10.00
10.30
10.49
10.79
11.08
11.27
11.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharming Group (PHAR) Moving Averages

Jun 17, 2025, 06:44 PM
Period
Simple
Exponential
MA5
11.40Sell
11.36Sell
MA10
11.58Sell
11.33Sell
MA20
11.02Buy
10.97Buy
MA50
9.63Buy
10.10Buy
MA100
9.17Buy
9.51Buy
MA200
8.82Buy
8.98Buy
Pharming Group’s (PHAR) 10-Day exponential moving average is 11.33, while Pharming Group’s (PHAR) share price is $11.32, making it a Sell.
Pharming Group’s (PHAR) 100-Day exponential moving average is 9.51, while Pharming Group’s (PHAR) share price is $11.32, making it a Buy.
Pharming Group’s (PHAR) stock price is $11.32 and Pharming Group’s (PHAR) 50-day simple moving average is 9.63, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $11.32 and Pharming Group’s (PHAR) 100-day simple moving average is 9.17, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $11.32 and Pharming Group’s (PHAR) 200-day simple moving average is 8.82, creating a Buy signal.

Pharming Group (PHAR) Technical Indicators

Jun 17, 2025, 06:44 PM
Name
Value
Implied Action
RSI (14)
55.54
Neutral
STOCH (9,6)
41.18
Neutral
STOCHRSI (14)
49.81
Neutral
MACD (12,26)
0.53
Buy
ADX (14)
16.54
Buy
Williams %R
-49.81
Buy
CCI (14)
34.71
Neutral
ATR (14)
0.65
-
Ultimate Oscillator
49.47
Neutral
ROC
4.81
Buy
Pharming Group’s (PHAR) Relative Strength Index (RSI) is 55.54, creating a Neutral signal.
Pharming Group’s (PHAR) Trend Strength Indicator (ADX) is 16.54, creating a Buy signal.
Pharming Group’s (PHAR) Commodity Channel Index (CCI) is 34.71, creating a Neutral signal.
Pharming Group’s (PHAR) Price Rate of Change (ROC) is 4.81, creating a Buy signal.

FAQ

Is PHAR a Buy, Hold, or Sell?
Based on PHAR’s technical indicators, PHAR is a Buy.
    What is PHAR’s RSI (14)?
    PHAR’s RSI (14) is 55.54, which suggests PHAR is a Neutral.
      What is PHAR’s MACD?
      PHAR’s MACD is 0.53, which suggests PHAR is a Buy.
        What is PHAR’s 5-day moving average?
        PHAR’s 5-day moving average is 11.40, which suggests PHAR is a Sell.
          What is PHAR’s 20-day moving average?
          PHAR 20-day moving average is 11.02, which suggests PHAR is a Buy.
            What is PHAR’s 50-day moving average?
            PHAR’s 50-day moving average is 9.63, which suggests PHAR is a Buy.
              What is PHAR’s 200-day moving average?
              PHAR’s 200-day moving average is 8.82, which suggests PHAR is a Buy.
                What is PHAR’s Williams % R (14)?
                PHAR’s Williams % R (14) is -49.81, which suggests PHAR is a Buy.
                  What is PHAR’s CCI (14)?
                  PHAR’s CCI (14) is 34.71, which suggests PHAR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis